Literature DB >> 652049

In vivo method for quantitation for anti-platelet potency of drugs.

R J Gryglewski, R Korbut, A Ocetkiewicz, J Stachura.   

Abstract

Aortic strips from atherosclerotic rabbits or Achilles tendons from healthy rabbits were superfused with blood (3 ml/min) from anaesthetized and heparinized cats, while blood was returned to the venous system of animals. The superfused tissues gained in weight because of deposition of platelet thrombi on their surface. This gain in weight was continuously monitored and quantified. Forty minutes after intravenous administration of indomethacin (14 mg/kg), aspirin (7 mg/kg) or nictindole (2 mg/kg) the formation of platelet depostis was reduced by half. Three hours after i.v. administration of each drug at a dose of 20 m;/kg the remaining anti-platelet activities were 92% for aspirin, 59% for indomethacin and 18% for nictindole as compared to their antithrombotic action, which was recorded 40 min after their administration. Thrombogenesis was also prevented by a direct infusion of nictindole (50 ng/ml) or indomethacin (2000 ng/ml) into a stream of superfusing blood. Thereby our method enables us to quantify in vivo anti-aggregating potency of drug, to estimate the duration of this action, and to compare their in vitro and in vivo aggregation-inhibitory activities.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 652049     DOI: 10.1007/BF00586592

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  Effects of anti-inflammatory drugs on prostaglandin biosynthesis.

Authors:  R Flower; R Gryglewski; K Herbaczyńska-Cedro; J R Vane
Journal:  Nat New Biol       Date:  1972-07-26

2.  The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi.

Authors:  H R Baumgartner
Journal:  Microvasc Res       Date:  1973-03       Impact factor: 3.514

3.  Cholesterol esterifying enzymes of atherosclerotic rabbit intima.

Authors:  J W Proudlock; A J Day
Journal:  Biochim Biophys Acta       Date:  1972-04-18

4.  Platelet participation in blood coagulation aspects of hemostasis.

Authors:  A J Webber; S A Johnson
Journal:  Am J Pathol       Date:  1970-07       Impact factor: 4.307

5.  Selective inhibition of thromboxane A2 biosynthesis in blood platelets.

Authors:  R J Gryglewski; A Zmuda; R Korbut; E Krecioch; K Bieron
Journal:  Nature       Date:  1977-06-16       Impact factor: 49.962

6.  Measurement of platelet aggregation in flowing blood with the use of a filter.

Authors:  G Hornstra; S Y Gielen
Journal:  Pathol Biol (Paris)       Date:  1974-11

7.  Release of prostaglandin F1alpha and F2alpha from superfused platelets: quantitative evaluation of the inhibitory effects of some aspirin-like drugs.

Authors:  C Patrono; G Ciabattoni; D Crossi-Belloni
Journal:  Prostaglandins       Date:  1975-04

8.  Effects of anticoagulation on the interaction of human platelets with subendothelium in flowing blood.

Authors:  H R Baumgartner
Journal:  Schweiz Med Wochenschr       Date:  1976-10-02

9.  Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.

Authors:  R J Gryglewski; S Bunting; S Moncada; R J Flower; J R Vane
Journal:  Prostaglandins       Date:  1976-11

10.  Prostaglandin and thromboxane biosynthesis inhibitors.

Authors:  R J Gryglewski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977       Impact factor: 3.000

View more
  5 in total

1.  Lungs as a generator of prostacyclin--hypothesis on physiological significance.

Authors:  R J Gryglewski; R Korbut; A Ocetkiewicz; J Spławiński; B Wojtaszek; J Swies
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-08       Impact factor: 3.000

2.  The study of platelet aggregation in whole blood [proceedings].

Authors:  D C Cardinal; R J Flower
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

3.  Determination of specific inhibitors of thromboxane A2 formation.

Authors:  N Ladd; G P Lewis
Journal:  Br J Pharmacol       Date:  1980-05       Impact factor: 8.739

4.  Release of prostacyclin from the human pulmonary vascular bed in response to cholinergic stimulation.

Authors:  R Brandt; A Dembińska-Kieć; R Korbut; R J Gryglewski; J Nowak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

5.  Estimated rate of prostacyclin secretion into the circulation of normal man.

Authors:  G A FitzGerald; A R Brash; P Falardeau; J A Oates
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.